Acro Biomedical appoints new chairman and CEO; Su resigns

ACRO BIOMEDICAL CO., LTD.

Yu-Ting Su resigned as director, chairman, and CEO on Sept 2, 2026, effective immediately.
Board appointed Shao-Hsiang Shih as director and chairman, effective Sept 2, 2026.
Jing-Zhou Chen appointed CEO and CFO, effective Sept 2, 2026.
Su's resignation was not due to any disagreement with the company.

item 5.02

ACRO BIOMEDICAL CO., LTD. filing history →

Source: SEC EDGAR

accession 0001640334-26-001447

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.